News Sobi cuts staff and buys Novimmune drug in refocus Sobi has narrowed its focus to haematology and immunology, shedding staff and R&D projects in other areas whilst taking full control of a drug it licenses from Novimmune.
News Janssen announces first data centres for haematology network Janssen has announced the first two data centres to join its HONEUR (Haematology Outcome
Novartis Novartis adds Promacta to breakthrough status roll-call Drug could get new indication based on NIH research
News Bavarian Nordic has found its new CEO Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
